RESEARCH-USE BIOSIMILAR ANTIBODY

Pulocimab

Monoclonal antibody · IgG1

KDRIgG1RUO

Pulocimab is an anti-VEGFR2 monoclonal antibody (mAb). Pulocimab can be used for the research of cancers.

TARGETKDR
YMonoclonal antibody
CATALOGSC-BS-249
CATALOG NUMBERSC-BS-249
MOLECULAR WEIGHTApprox. 143.721 kDa
PRODUCT FORMATMonoclonal antibody

A research-use configuration for comparative antibody studies

Pulocimab is an anti-VEGFR2 monoclonal antibody (mAb). Pulocimab can be used for the research of cancers.

Pulocimab is a recombinant research-use antibody directed against KDR.

START A CONVERSATION

Tell us about your research goals.

For quotes, sample requests or technical support, start with your target and experimental context.

Contact StellaCyte
Pulocimab | StellaCyte